GlobalSTL’s Post

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #GlobalOpenSurgicalStaplerMarket #MedicalDevices #SurgicalInnovation #HealthcareGrowth #PatientCare #SurgicalTools #MarketAnalysis #HealthTech #SurgeryTrends #MedicalResearch

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #MedicalDevices #SurgicalRetractors #HealthcareInnovation #MinimallyInvasiveSurgery #PatientCare #SurgicalPrecision #GlobalMarket #MedicalTechnology #HealthcareAdvancements #SurgicalOutcomes

Ready to enhance patient outcomes and practice growth? Dive into our report for expert insights on integrating shockwave and EMTT therapies into your continuum of care. Get key takeaways from the Institute medical conference and learn best practices for technology integration. https://hubs.la/Q02BMG900

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #MedicalDevices #HealthcareInnovation #SurgicalLighting #LEDHeadlights #XenonLamps #HalogenLamps #MedicalTechnology #PatientCare #HealthcareMarket #MedicalResearch

𝐀𝐈-𝐏𝐨𝐰𝐞𝐫𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐟𝐨𝐫 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: 𝐂𝐮𝐫𝐫𝐞𝐧𝐭 𝐒𝐭𝐚𝐭𝐮𝐬 𝐚𝐧𝐝 𝐅𝐮𝐭𝐮𝐫𝐞 𝐃𝐢𝐫𝐞𝐜𝐭𝐢𝐨𝐧𝐬 AI is reshaping cardiovascular healthcare by enhancing diagnostics, enabling real-time patient monitoring, and delivering personalized care. As of August 2024, the cardiovascular sector comprises 97 FDA-cleared AI/ML devices, with 52 Software as a Medical Device (SaMD) and 45 Software in a Medical Device (SiMD). These innovations are transforming inpatient and outpatient care through decision support tools (51 devices), continuous monitoring systems (33 devices), and remote patient monitoring (10 devices), empowering home-based care. Major contributors, including HeartFlow, Medtronic, AliveCor, and Apple, demonstrate the competitive yet collaborative landscape driving innovation. Key use cases include non-invasive coronary assessments, remote ECG monitoring, AI-integrated wearables, and predictive hospital decision support tools like the Rothman Index. Future developments point to more advanced personalized care through adaptive AI monitoring, virtual healthcare integration, and AI-guided interventions. With the convergence of wearables, telemedicine, digital therapeutics, and federated learning, AI will redefine cardiovascular care, ensuring proactive interventions, seamless patient management, and improved outcomes. Video Linked: https://lnkd.in/eq9aJdUS We are excited to invite you to our upcoming webinar, “Digital Health Regulatory & Reimbursement Frameworks for HealthTech Professionals.” This webinar is designed to provide healthtech professionals with an in-depth understanding of the regulatory and reimbursement frameworks that govern the development and commercialization of digital health products in the U.S. healthcare market. It will offer comprehensive insights into navigating the FDA's complex regulatory pathways, understanding the exclusions under the 21st Century Cures Act, and exploring coding and coverage strategies that are essential for market success. By the end of this session, participants will be equipped with the knowledge and tools necessary to effectively navigate the regulatory and reimbursement landscape, ensuring their digital health products are compliant, innovative, and market-ready. Agenda SaMD & AI/ML-Enabled Medical Devices FDA Regulatory Frameworks FDA-Approved SaMD & AI/ML-Enabled Medical Devices Landscape  Digital Health Products FDA Regulatory Frameworks Digital Health Coding & Coverage Pathways Global Perspective: S. Korea & Germany Date/Time October 17, 2024 (Thu) | 12:00 pm - 1:00 pm ET Register Here: https://lnkd.in/eBHNusam #DigitalHealth, #HealthTech, #FDARegulation, #SaMD, #Reimbursement, #MedicalDevices, #DigitalTherapeutics, #AIinHealthcare, #Telehealth, #HealthTechInnovation, #HealthcareCompliance

The first global open-access platform provides comprehensive medical device information covering 2,301 device types! The World Health Organization has launched MeDevIS (Medical Devices Information System), designed to help governments, regulators, and consumers make informed decisions about selecting, buying, and using medical devices for various health conditions. By using international data standards like the European Medical Device Nomenclature (EMDN) and the Global Medical Device Nomenclature (GMDN), MeDevIS makes registering, procuring, and tracking medical devices easier. How do you think this new platform will impact the global healthcare landscape? https://lnkd.in/emn5eNkn #healthtech #medicaldevice #medtech #health #healthcare

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #MedicalContrastCatheter #GlobalMarket #HealthcareInnovation #DiagnosticImaging #CardiovascularHealth #MinimallyInvasive #MedicalDevices #HealthcareTrends #PatientCare #AdvancedDiagnostics

There are gaps in the Healthcare and MedTech industry. I had a bit of a chat with the team at Meditech Today on the future of the MedTech industry from a digital transformation and marketing perspective. As a digital partner in this space, we usually sit in (or around) the gaps between the clinical experts, the tech engineers, the device distribution and sales teams, and the patients. But my aim for us is to not just be a gap-filler. Our role when properly embraced and executed within the Healthcare and MedTech unit is, should be, could be... to be the bridge that helps connect the divide, and helps move the conversation. And I want to talk about that.

Are you commercializing a medical device in women’s health? You might be interested in a few insights from a recent fireside chat in New York, where I shared the story behind our journey from concept to exit. Last week, I had the pleasure of sharing our story live in New York for a fireside chat held at NYU Tandon Future Labs, hosted by Vadim Gordin. We were also joined by Hrishikesh (Rishi) Deo, Ph.D., former senior leader at Pentax's medical device group who is currently developing a robotic colonoscopy device as the founder and CEO of Ergami Endoscopy. I gave a brief presentation on the following: - The story behind our device, inspired by a high-risk and complicated birth. - How to take a device from initial concept to expansion across multiple international markets. - How we navigated the sales cycle for a high-risk medical device, one where we couldn’t support live cases, due to its use in an emergency setting - How our successful commercialisation efforts over 10 years (3 years in the US) led to our company being acquired by a leader in the field, CooperSurgical. - The key value drivers behind our company sale, including intellectual property, clinical data, hospital adoption, and our distribution strategy The floor then opened for a Q&A session. I have picked out a few key themes from that discussion to share in this month’s OBG Access Newsletter, in the hopes that it will both inspire and educate others on a similar journey. Sign up using the link in the comments or from my bio. In this newsletter, I share responses to the following questions: - How did your US commercialisation effort compare with the UK and European markets? - How did you navigate hospital group purchasing committees and what was your reimbursement strategy? - How did the relationship with CooperSurgical develop? - What were the key value drivers behind your exit? - Looking back, what would you have done differently? Sign up to the newsletter being published on Monday. Any questions, feel free to reach out! Thanks Alex Koshykov for the pictures, look forward to our podcast, out soon! #Innovation #MedicalDevices #WomensHealth #Obstetrics #Commercialization #FiresideChat #NewYork

Staying up-to-date with the latest innovations is essential, especially for those of us working in healthcare innovation. Great ideas have the power to inspire others, creating a virtuous cycle that transforms the entire industry. Today, I’m excited to share with you a list of the most innovative medical devices of 2024, selected by The Galien Foundation. Among them are a portable ultrasound system and an automated insulin delivery system. Curious to know more? Check out the full list at the link: #medicaldevices #healthtech #medtech #innovation #healthcare